British Medical JournalWHO Alliance for Health Policy and Systems Research
…gaining attention in global health in the early 2000s, when the British Medical Journal published a series centred around complexity science applicatio…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 901–960 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
A2 Bio2AIIMS2Acandis2American Society for Radiation Oncology2Aspen Medical2Australian and New Zealand Clinical Trials Registry2C57BL/62CASSISS2CCMG2COLUMBUS2Centre A2Centre B2ClinGen2EPIC2Guangdong Provincial People’s Hospital2Hospital B2IIT2ITU2JKS2NHNN2NRAP2NeoGenomics2PCI centre2RACPC2RSU2Royal Pharmaceutical Society2SHINE2SPIROMICS2Sanford Burnham Prebys2Siemens Healthineers2TARGET2UCSF2UGCED2UKBB2UKPDS2UNC2University of Texas Southwestern Medical Center2VigiBase2cardiology journals2study centre210X Genomics2AASLD2ACM Digital Library2AGRICAN cohort2ANZCTR2ASCS2Affiliated Hospital of Qingdao University2All of Us Research Program2American Academy of Pain Medicine2Arizona State University2Arthritis Rheumatol2Austin Health2Australia New Zealand Clinical Trials Registry2BRONCHUK2Baylor College of Medicine2Birmingham Heartlands Hospital2Blackpool Victoria Hospital2British Cohort Study2C4-Egypt2CADTH2
Articles mentioning institutions
11,350 articles · page 249 of 946University of OttawaHôpital MontfortAI-CARE
…ch Ethics Boards of the Hôpital Montfort (24-25-11-038) and the University of Ottawa (S-12-24-11153) formally approved this study in December 2024. …
PRIME-UKparkinsonismtreatment escalation planPRIME-Parkinson careusual care
…is is a cross-sectional substudy of 211 participants within the PRIME-UK randomised controlled trial, a single-centre trial that randomi…
EuroQol GroupAmerican Society of Clinical Oncologycancer treatmentsbreast cancernon-small cell lung cancerEuropean Medicines AgencyUS Food and Drug AdministrationNSCLCBC
…Core 30-item (EORTC QLQ-C30) was used in 83 trials (79.0%), and EuroQol Group in 72 (68.6%). Only 10 products included PRO content in their r…
tertiary institutionsacute cholecystitiscalculous cholecystitisnon-malignant cholecystitisrecurrent cholecystitisEC-LAMS
… of recurrent cholecystitis.Conclusions EUS-GBD with EC-LAMS at tertiary institutions is a highly effective and relatively safe technique in patients…
VigiBaseefgartigimod alfaatrial fibrillationrecombinant interleukin-2recombinant interleukin-11AFimmunomodulators
…o (aROR) for AF reporting performed for 141 immunomodulators in VigiBase. Then, a literature review was done to explore the underlying m…
Department of OrthopaedicsLHGPSwedish Ethical Review AuthorityHIPSTER
…d controlled trial. Patients with LHGP (n=122), referred to the Department of Orthopaedics at a university hospital in Sweden, will be randomised into the…
British National Institute for Health and Care ExcellenceSTEADY-CANprostate cancerMicrocytosisMacrocytic anaemiamacrocytosiscolorectal cancerCRCincident cancerCancer+2 more
…r more severe anaemia) exceed the 3% risk threshold used in the British National Institute for Health and Care Excellence guidance for 2-week-wait referral, supporting rapid investigati…
McGill UniversityCanadian Institutes of Health Research
…y of Medicine and Health Sciences Institutional Review Board at McGill University approved the study’s protocol (24-05-080). Results will be subm…
Money et alattention-deficit/hyperactivity disorderasthmadevelopmental disabilities
…n-deficit/hyperactivity disorder or developmental disabilities. Money et al conducted a systematic review of the 2023–2024 literature to id…
Hunter New England Human Research Ethics Committeestroke
…thics approval for the control population was obtained from the Hunter New England Human Research Ethics Committee (HNEHREC Reference No. 13/02/20/5.06) with further amendment (A…
tertiary university hospitalregional hospitalStage IVA right oropharyngeal cancernutritional supportsquamous cell carcinoma
…had been placed approximately 2.5 years (900 days) earlier at a tertiary university hospital for nutritional support during treatment for Stage IVA right or…